MedTrace Logo

Maintenance Therapy of Narrow-band UV-B Therapy in Patients With Vitiligo

NCT03384342 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-12-27

No results posted yet for this study

Summary

Although vitiligo is difficult to cure, recurrences are frequent after treatment, and many patients suffer from concerns about recurrence as well as disease. Psoriasis, another indication for ultraviolet radiation treatment, has been established that it can safely and effectively reduce the recurrence of psoriasis through monthly maintenance therapy.

The aim of this study was to evaluate the efficacy of Narrow-band UV-B therapy for the prevention of relapse in vitiligo.

Conditions

  • Phototherapy
  • Vitiligo
  • Maintenance Therapy
  • Narrow-band UV-B

Interventions

DEVICE

Narrow-band UV-B therapy

* Patients treated with NBUVB and showed 75% or more repigmentation rate would be included. * For a total period of 12 months, narrow-band UV-B therapy is performed once a month.

Sponsors & Collaborators

  • The Catholic University of Korea

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-18
Primary Completion
2018-11-18
Completion
2019-05-18

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03384342 on ClinicalTrials.gov